Autogynephilia:The Study Activists Wanted Buried - Dr. Ray Blanchard (#41)
3 October 2025
With Dr. Ray Blanchard
therapy-and-psychology
Ray Blanchard's concept of autogynephilia—describing sexual arousal in some males at the image of themselves as female—emerged from fifteen years of careful clinical work. It also became one of the most politically targeted ideas in the history of gender medicine. This episode examines why. Not to relitigate the science in isolation, but to ask what it reveals when a research community allows activist pressure to determine which findings are permissible. Blanchard's experience is a precise case study in how ideological capture takes hold inside institutions—and what is lost when it does.
Ray Blanchard spent fifteen years working inside a gender identity clinic, accumulating clinical knowledge that only comes from sustained, direct work with patients over time. Out of that work came a framework for understanding male-to-female transsexualism that distinguished two separate pathways, each with its own psychological profile. The concept he gave a name to—autogynephilia—described a distinct erotic orientation in which a man is sexually aroused by the thought or image of himself as female. It was not about cross-dressing as such, but about something more specific: a self-directed sexuality with real implications for how gender dysphoria is understood and treated. His 1989 paper introduced this framework to the clinical literature. What followed was not the normal process of debate, refinement, and eventual resolution on evidential grounds. Blanchard's work became a political flashpoint. Activists and their allies in academia moved against it not on technical grounds but because the conclusions were deemed unacceptable—that naming an erotic component in the motivation of some trans-identified males was seen as delegitimising, even dehumanising. This is where the episode opens onto something larger than any single debate about sexual psychology. What Blanchard's story illustrates is a pattern that has repeated itself across gender medicine: the subordination of clinical evidence to ideological imperatives. When a finding does not fit the preferred narrative—that gender identity is an innate, fixed characteristic unconnected to sexuality or social context—the institutions that should be adjudicating scientific disputes have instead been pressured into silence. The question at the centre of the conversation is not simply whether Blanchard was right, but what it means for medicine when that question is settled by activists rather than evidence. Blanchard brings an unusual combination of qualities to the conversation: the patience of a clinician who spent years in direct contact with patients, the precision of a researcher committed to defining his concepts carefully, and the equanimity of someone who has watched his work be deliberately misrepresented for decades without abandoning it. His account of what happened—how a carefully developed clinical framework was treated once it became politically inconvenient, how standard processes of scientific debate were bypassed in favour of suppression—is a case study in how knowledge gets buried when it conflicts with an ideological programme. The broader lesson concerns what happens downstream when medicine allows its own standards to be overridden by advocacy. If the two-pathway model was suppressed rather than properly contested, clinicians lost access to a framework that might have helped them distinguish between patients with very different needs. The medicalisation of gender dysphoria—affecting adults and, increasingly, children—proceeded on assumptions shielded from scrutiny. Blanchard's conversation with the Beyond Gender hosts is a reminder that the cost of ideologically driven science is not confined to academic journals. It is borne by the people whose care depends on accurate understanding.
